ArticleChildren (Basel, Switzerland)2022

A Multicenter Study Evaluating the Discontinuation of Eculizumab Therapy in Children with Atypical Hemolytic Uremic Syndrome.

Saeed AlZabali et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.